Among those with available data for cytogenetics, high‐risk cytogenetics were less frequent among long‐term survivors (14.3% versus 31.6%, respectively), although this difference did not reach statistical significance.
← all excerpts
Determinants of 15-Year Progression-Free Survival in Multiple Myeloma; Real-World Data From a Single Institution.
1
—
—